Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-09-22 to 2022-10-14
Current total value of award: $10208.07
Description: 4558554693!HYPERRAB 300 UNIT/ML VIAL 3ML